Task: Answer Verification
Input (English): Question: Does full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF increase chemotherapy-induced febrile neutropenia?
Answer: Full-dose adjuvant chemotherapy may be given to patients with ESBC regardless of the day-before ANC, without significantly increasing the risk of CIFN. The chemotherapy regimen is the most significant predictor for CIFN.
Output (English): no